Treatment of retroviral induced dementia by administration of 2'

Details Treatment of retroviral induced dementia by administration of 2' Treatment of retroviral induced dementia by administration of 2'

1993-03-01

1994-12-27

Rollins, John W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

536 278, A61K 3170

Patent

active

053766423

ABSTRACT:
A preferred method and dosages for treatment of retrovirus-induced dementia by the administration of 2',3'-dideoxyinosine(ddI) is disclosed.

REFERENCES:
patent: 3817982 (1974-06-01), Verheyden et al.
patent: 4704357 (1987-11-01), Mitsuya et al.
patent: 4861759 (1989-08-01), Mitsuya et al.
patent: 5026687 (1991-06-01), Yarchoan et al.
Johnson et al., J. Biol. Chem., 263(30), 15,354-15,357 (1988).
Lee et al., Antimicrobial Agents and Chemotherapy, 33(3), 336-339 (1989).
Tavares et al., Chem. Abst., 110(23):204,955q (1989).
Hao et al., Chem. Abstr., 109(25), 222,009t (1988).
Cooley et al., The New England J. Med., 322, 1340-1345 (1990), first page only.
Lambert et al., The New England J. Med., 322, 1333-1340 (1990).
"A Note to Physicians", National Institutes of Health, Nov. 1, 1989, pp. 1-4.
Yarchoan et al., "Escalating Dose Phase I Study of Intravenous and Oral 2',3'-dideoxyinosine (DDI) in Patients with AIDS or ARC", Section B, Abstract 4 in V International Conference on AIDS, International Development Research Center, Montreal, Calif, Jun. 8, 1989, see whole document.
Busso et al., AIDS Research and Human Retroviruses, 4(6), 449-455 (1988).
Yarchoan et al., "Long-term Toxicity/Activity Profile of 2',3'-Dideoxysine AIDS or AIDS-Related Complex", The Lancet, 336, 526-529 (1990).
Yarchoan et al., "In Vivo-Activity Against HIV and Favorable Toxicity Pro of 2',3'-Dideoxyinosine", Science, 245, 412-415 (1989).
Butler et al., "Dideoxyinosine (ddI) in Children with Symptomatic HIV Infection. A Phase I-II Study", Abstract No. 34, Program and Abstracts of the Twenty-Ninth Interscience Conference on Microbial Agents and Chemotherapy, American Society for Microbiology, Sep. 20, 1989, Houston, Tex.
Yarchoan et al., J. Cellular Biochemistry, Supplement 13B, "UCLA Symposium on Molecular and Cellular Biology", Jan. 21, 1989, See Abstract G451.
Yarchoan et al., "The National Institutes of Health Phase I Study of 2',3'-Dideoxyinosine Administration in Adults with AIDS-Related Complex: Analysis of Activity Toxicity Profiles", Review of Infectious Diseases, 12(Supp. 5), S522-S533 (1990).

Affiliated with

Also associated with

Rating

Treatment of retroviral induced dementia by administration of 2' does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of retroviral induced dementia by administration of 2', we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of retroviral induced dementia by administration of 2' will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-919844